Characteristics and treatment results of refractory and relapsed acute myeloid leukaemia in paediatric patients treated in Polish Paediatric Leukaemia/Lymphoma Study Group institutions according to the Protocol Acute Myeloid Leukaemia BerlinFrankfurt-Munster 2012 and a review of novel treatment possibilities in paediatric acute myeloid leukaemia

被引：0

作者：

Samborska, Magdalena ^{[1
,18
]}

Skalska-Sadowska, Jolanta ^{[1
]}

Achkar, Robert ^{[2
]}

Wachowiak, Jacek ^{[1
]}

Derwich, Katarzyna ^{[1
]}

Czogala, Malgorzata ^{[3
]}

Balwierz, Walentyna ^{[3
]}

Skoczen, Szymon ^{[3
]}

Dobaczewski, Grzegorz ^{[4
]}

Chybicka, Alicja ^{[4
]}

Kalwak, Krzysztof ^{[4
]}

Krawczuk-Rybak, Maryna ^{[5
]}

Muszynska-Rostan, Katarzyna ^{[5
]}

Adamkiewicz-Droiynska, Elzbieta ^{[6
]}

Maciejka-Kapuscinska, Lucyna ^{[6
]}

Irga-Jaworska, Ninela ^{[6
]}

Pohorecka, Joanna ^{[7
]}

Chodata-Grzywacz, Agnieszka ^{[7
]}

Karolczyk, Graiyna ^{[7
]}

Wojcik, Beata ^{[7
]}

Kowalczyk, Jerzy R. ^{[8
]}

Drabko, Katarzyna ^{[8
]}

Zawitkowska, Joanna ^{[8
]}

Mycko, Katarzyna ^{[9
]}

Badowska, Wanda ^{[9
]}

Ociepa, Tomasz ^{[10
]}

Urasinski, Tomasz ^{[10
]}

Sikorska-Fic, Barbara ^{[11
]}

Matysiak, Michal ^{[11
]}

Laguna, Pawel ^{[11
]}

Dabrowska-Pawliszyn, Anna ^{[12
]}

Tomaszewska, Renata ^{[12
]}

Szczepanski, Tomasz ^{[12
]}

Sobol, Graiyna ^{[13
]}

Mizia-Malarz, Agnieszka ^{[13
]}

Ciebiera, Malgorzata ^{[14
]}

Chaber, Radoslaw ^{[14
]}

Koltan, Sylwia ^{[15
]}

Wysocki, Mariusz ^{[15
]}

Styczynski, Jan ^{[15
]}

Woszczyk, Mariola ^{[16
]}

Wieczorek, Maria ^{[16
]}

Karpinska-Derda, Irena ^{[16
]}

Urbanska-Rakus, Justyna ^{[16
]}

Bobeff, Katarzyna ^{[17
]}

Trelinska, Joanna ^{[17
]}

Mlynarski, Wojciech ^{[17
]}

机构：

[1] Univ Med Sci, Dept Pediat Hematol Oncol & TransplantolOncol & T, Poznan, Poland

[2] Univ Med Sci, Poznan, Poland

[3] Univ Children Hosp, Dept Pediat Oncol & Hematol, Krakow, Poland

[4] Wroclaw Med Univ, Clin Dept Pediat Bone Marrow Transplantat Oncol &, Wroclaw, Poland

[5] Med Univ, Dept Pediat Oncol & Hematol, Bialystok, Poland

[6] Med Univ, Dept Pediat Hematol & Oncol, Gdansk, Poland

[7] Reg Polyclin Hosp, Dept Pediat Hematol & Oncol, Kielce, Poland

[8] Med Univ, Dept Pediat Hematol Oncol & Transplantol, Lublin, Poland

[9] Prov Childrens Hosp, Dept Pediat & Hematol & Oncol, Olsztyn, Poland

[10] Pomeranian Med Univ, Dept Pediat HematoOncol & Gastroenterol, Szczecin, Poland

[11] Med Univ, Dept Oncol Pediat Hematol Transplantol & Pediat, Warsaw, Poland

[12] Silesian Univ Med, Dept Pediat Hematol & Oncol, Zabrze, Poland

[13] Med Univ Silesia, Katowice, Poland

[14] Clin Prov Hosp, Dept Pediat Oncohematol, Rzeszow, Poland

[15] Nicolaus Copernicus Univ Torun, Dept Pediat Hematol & Oncol, Coll Medicum, Bydgoszcz, Poland

[16] Pediat Ctr, Dept Pediat Hematol & Oncol, Chorzow, Poland

[17] Med Univ, Dept Pediat Oncol & Hematol, Lodz, Poland

[18] Uniwersytet Med Karola Marcinkowskiego, Klin Onkol Hematol & Transplantol Pediat, Poznan, Poland

来源：

WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY | 2023年 / 27卷 / 04期

关键词：

children; acute myeloid leukaemia; relapse; refractory; novel therapies; CHILDREN; RECOMMENDATIONS; CHEMOTHERAPY; CYTARABINE; MANAGEMENT; DIAGNOSIS;

D O I：

10.5114/wo.2023.135327

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Introduction: This study aimed to present the clinical features and results of treatment of patients diagnosed with refractory or relapsed acute myeloid leukaemia (AML) in Polish Paediatric Leukaemia/Lymphoma Study Group (PPL/LSG) institutions, treated in accordance with the Protocol Acute Myeloid Leukaemia Berlin -Frankfurt -Munster 2012, as their first -line therapy. Material and methods: The outcome data of 10 patients with refractory AML (median age 9.5 years) and 30 with relapsed AML (median age 12 years) were analysed retrospectively. Re -induction was usually based on idarubicin, fludarabine, and cytarabine along with allogeneic haematopoietic stem cell transplant (allo-HSCT) in 5 patients with refractory AML and 7 relapsed AML children. Results: 37.5% (3/8) of refractory AML patients achieved second complete remission second complete remission (CRII). One of ten patients (1/10; 10%) was alive and stayed in complete remission for 34 months after the allo-HSCT. The probability of 3 -year event -free survival (pEFS) in this group was 0.125 +/- 0.11. In the group of relapsed AML patients, the CRII was achieved in 9 patients (34%), and the probability of survival was: pEFS = 0.24 +/- 0.08; probability overall survival (pOS) = 0.34 +/- 0.09, with significantly better results achieved in patients who underwent allo-HSCT (pOS = 0.54 +/- 0.14 vs. 0.08 +/- 0.08, p < 0.0001). Conclusions: The prognosis of refractory AML and the first AML recurrence in children who were first -line treated in PPL/LSG centres according to Protocol Acute Myeloid Leukaemia Berlin -Frankfurt -Munster 2012 is poor. Failures of re -induction treatment particularly result from difficulties in achieving remission. Allogeneic HSCT improves prognosis in children with refractory and first recurrent AML, under the condition it is performed in complete remission. Novel therapeutic approaches are needed to increase the remission rate and improve the outcomes.

引用

页码：249 / 254

页数：6

共 50 条

[21] Serial Evaluation of T cell Subsets in Paediatric Acute Myeloid Leukaemia- a Prospective Study
Anuj Kumar Bansal
Surender Kumar Sharawat
Ritu Gupta
Sreenivas Vishnubhatla
Sameer Bakhshi
Indian Journal of Hematology and Blood Transfusion, 2022, 38 : 153 - 157
[22] Serial Evaluation of T cell Subsets in Paediatric Acute Myeloid Leukaemia- a Prospective Study
Bansal, Anuj Kumar
Sharawat, Surender Kumar
Gupta, Ritu
Vishnubhatla, Sreenivas
Bakhshi, Sameer
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2022, 38 (01) : 153 - 157
[23] Early UK experience in the use of clofarabine in the treatment of relapsed and refractory paediatric acute lymphoblastic leukaemia
O'Connor, David
Sibson, Keith
Caswell, Mark
Connor, Philip
Cummins, Michelle
Mitchell, Chris
Motwani, Jayashree
Taj, Mary
Vora, Ajay
Wynn, Robert
Kearns, Pamela R.
BRITISH JOURNAL OF HAEMATOLOGY, 2011, 154 (04) : 482 - 485
[24] Treatment outcomes of paediatric acute myeloid leukaemia in Western Kenya before and after the implementation of the SIOP PODC treatment guideline
Wijnen, Noa
van Weelderen, Romy
Njuguna, Festus
Klein, Kim
Vik, Terry
Olbara, Gilbert
Kaspers, Gertjan
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2023, 28 : 349 - 350
[25] Impact of genotype in relapsed and refractory acute myeloid leukaemia patients treated with clofarabine and cytarabine: a retrospective study
Mondesir, Johanna
Alary, Anne-Sophie
Sibon, David
Willems, Lise
Deau, Benedicte
Suarez, Felipe
Hermine, Olivier
Fontenay, Michaela
Bouscary, Didier
Kosmider, Olivier
Tamburini, Jerome
BRITISH JOURNAL OF HAEMATOLOGY, 2019, 187 (01) : 65 - 72
[26] Using a Screening Technique to Identify New Combination Therapies with Potential to Improve Treatment of Paediatric Acute Myeloid Leukaemia
Lappin, K.
Davis, L.
Matchett, K.
Blayney, J.
Mills, K.
BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 : 38 - 38
[27] Outcome after intensive reinduction therapy and allogeneic stem cell transplant in paediatric relapsed acute myeloid leukaemia
Karlsson, Lene
Forestier, Erik
Hasle, Henrik
Jahnukainen, Kirsi
Jonsson, Olafur G.
Lausen, Birgitte
Nystrom, Ulrika Noren
Palle, Josefine
Tierens, Anne
Zeller, Bernward
Abrahamsson, Jonas
BRITISH JOURNAL OF HAEMATOLOGY, 2017, 178 (04) : 592 - 602
[28] A MULTICENTER PHASE I-II STUDY OF TOSEDOSTAT IN THE TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKAEMIA
Ossenkoppele, G.
Hooftman, W.
Zweegman, S.
Davies, E.
Morgan, G.
Mueller-Tidow, C.
Krug, U.
Duhrsen, U.
Burnett, A.
Jenkins, C.
Zachee, P.
Dierickx, D.
Lowenberg, B.
Sonneveld, P.
Hooftman, L.
Richardson, A.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 429 - 429
[29] Treatment of elderly patients with acute lymphoblastic leukaemia using a paediatric-based protocol
Martell, Marc Poch
Atenafu, Eshetu G.
Minden, Mark D.
Schuh, Andre C.
Yee, Karen W. L.
Schimmer, Aaron D.
Gupta, Vikas
Brandwein, Joseph M.
BRITISH JOURNAL OF HAEMATOLOGY, 2013, 163 (04) : 458 - 464
[30] Clofarabine and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute myeloid leukaemia
Eric Tse
Anskar Y. H. Leung
Joycelyn Sim
Harold K. K. Lee
Herman S. Y. Liu
Sze-Fai Yip
Yok-Lam Kwong
Annals of Hematology, 2011, 90 : 1277 - 1281

← 1 2 3 4 5 →